David Moore to Antitubercular Agents
This is a "connection" page, showing publications David Moore has written about Antitubercular Agents.
Connection Strength
0,495
-
Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence? Clin Microbiol Infect. 2022 05; 28(5):631-633.
Score: 0,163
-
Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. PLoS One. 2015; 10(4):e0126099.
Score: 0,102
-
The resurgence of tuberculosis and the implications for primary care. Br J Gen Pract. 2013 Jul; 63(612):344-5.
Score: 0,090
-
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
Score: 0,076
-
Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019 03; 19(3):e77-e88.
Score: 0,033
-
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet. 2018 02; 50(2):307-316.
Score: 0,031